1 completed, 1 terminated, 1 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Atrial Fibrillation Recurrent: new trials by email Literature Review of Atrial Fibrillation Recurrent trials Research Report on Atrial Fibrillation Recurrent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation Sacubitril-valsartan, Valsartan - Atrial Fibrillation Recurrent, Hypertension | Phase 4 | Completed | Shanghai Jiao Tong University School of Medicine | 320 | 2023-02-06 | 2026-02-10 |
| Pulmonary Vein (PV) Imaging by Intracardiac Echography (ICE) After Ablation Atrial fibrillation ablation - Atrial Fibrillation Recurrent | Phase 4 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 18 | 2021-11-01 | 2023-03-27 |
| Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence dronedarone 400 mg Oral Tablet, Placebo - Atrial Fibrillation, Atrial Fibrillation Recurrent | Phase 4 | Terminated | Tulane University School of Medicine | 22 | 2021-05-15 | 2025-10-30 |
Arrhythmias, Cardiac (1) · Atrial Fibrillation (1) · Heart Murmurs (1) · Hypertension (1)
Cardiovascular Diseases (2) · Heart Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Vascular Diseases (1)
Dronedarone (1) · Tablets (1) · Valsartan (1) · sacubitril and valsartan sodium hydrate drug combination (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Shanghai Jiao Tong University School of Medicine (1) · Tulane University School of Medicine (1)
China (1) · Italy (1) · United States (1)
Gianluigi Bencardino, Dr (1) · Nassir F Marrouche, MD (1)